Procera Launches Virtualized PacketLogic Solutions
August 7th, 2013 By: John Rath
Internet Intelligence company Procera Networks (PKT) announced the launch of Virtualized PacketLogic solutions based on the European Telecommunications Standards Institute (ETSI) Network Functions Virtualization (NFV) standards. As an appliance, the solution will allow network operators to reduce the cost of acquisition and ownership for Internet Intelligence solutions.
“We’ve been noting a definite interest among operators toward virtualizing their policy decision and enforcement functions as a way to reduce costs and bring services to market more quickly,” said Shira Levine, Directing Analyst, Service Enablement and Subscriber Intelligence at Infonetics Research. “We believe that this trend will accelerate as Software Defined Networking (SDN) begins to gain traction, driving demand for DPI technology that can mine intelligence from the network and feed it up to the control layer.”
Any hardware solution that can run standard-based virtualization software can be deployed with the PacketLogic solution modules (PSM, PRE, and PIC), including deployments that run all of the modules on a single hardware platform. The Virtual PacketLogic solutions can be used for any portion of the lifecycle of a Policy Enforcement deployment from the initial functional evaluation, trial deployment, service rollout, bandwidth expansion, or geographic expansion.
“Virtualization is a natural evolution of the PacketLogic architecture,” said Alexander Havang, chief technology officer for Procera. “Procera has always maintained hardware independence, and has delivered the highest performing solutions available on the market using off-the-shelf hardware technology. We have used virtualization extensively internally, and our customers are asking to deploy this in their networks today. Speed to market with new services and the ability to deliver targeted niche services also becomes a much simpler and more rapid process.”
The Virtual PacketLogic solutions will be available for trial in the third quarter of 2013, and are expected to be generally available by the end of 2013.